Clinical Study
Effects of Repetitive Hyperbaric Oxygen Treatment in Patients with Acute Cerebral Infarction: A Pilot Study
Table 1
Baseline characteristics of the study participants.
| | HBOT group () | Controls () | value |
| Gender, male/female | 13/3 | 15/15 | 0.550 | Age (years) | 68.375 (32ā88) | 68.867 (44ā86) | 0.896 | Past history | 1.75 (0ā3) | 1.7 (0ā3) | 0.930 | Triglycerol (mg/dl) | 137.375 (52ā408) | 165.138 (50ā359) | 0.602 | T. cholesterol (mg/dl) | 181.313 (116ā290) | 201.833 (122ā282) | 0.176 | Homocysteine (Ī¼mol/L) | 11.54 (4.78ā16.36) | 11.27 (3.10ā20.45) | 0.122 |
| Clinical characteristics | | | | āRisk factor, yes/no | 3/13 | 14/16 | 0.569 | āAspirin, yes/no | 12/4 | 25/5 | 0.698 | āAnticoagulant, yes/no | 4/12 | 9/21 | 0.245 | āPiracetam, yes/no | 11/5 | 13/17 | 0.100 | āAntilipid agents, yes/no | 4/12 | 10/20 | 0.063 | āAntihypertensives, yes/no | 13/3 | 25/5 | 0.100 | āOral antidiabetics, yes/no | 7/9 | 11/19 | 0.100 | āRehabilitation, yes/no | 12/4 | 21/7 | 0.516 |
|
|